The balance sheet strengthened post-divestiture with total debt down to $15.7M and D/E of 0.04, yet goodwill of $208.6M (46.6% of assets) and a retained deficit of -$293.4M suggest the apparent health is partly inflated by one-time gains.
BioLife Solutions, Inc. (BLFS) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Jan'15 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Jun'96 |
|---|
| Total Current Assets | 135.2M | 136.56M | 148.76M | 120.6M | 138.45M | 125.86M | 114.71M | 24.18M | 37.56M | 9.93M | 4.63M | 6.97M | 12.17M | 1.88M | 1.63M | 1.16M | 814.97K | 892.37K | 1.04M | 569.58K | 515.66K | 384.85K | 704.26K | 2.84M | 156.13K | 851.2K | 3.03M | 1.29M | 1.93M | 2.87M | 7.32M |
| Cash & Short-Term Investments | 82.42M | 88.93M | 104.58M | 44.18M | 62.7M | 69.87M | 90.46M | 6.45M | 30.66M | 6.66M | 1.41M | 3.82M | 9.94M | 156.27K | 196.48K | 16.86K | 3.21K | 139.15K | 98.72K | 56.5K | 118.67K | 185.09K | 531.68K | 787.9K | 67.12K | 286.11K | 2.15M | 7.95K | 135.18K | 124K | 1.22M |
| Cash Only | 24M | 33.04M | 95.39M | 27.9M | 19.44M | 69.87M | 90.46M | 6.45M | 30.66M | 6.66M | 1.41M | 3.82M | 9.94M | 156.27K | 196.48K | 16.86K | 3.21K | 139.15K | 98.72K | 56.5K | 118.67K | 185.09K | 531.68K | 787.9K | 67.12K | 286.11K | 2.15M | 7.95K | 135.18K | 124K | 1.12M |
| Short-Term Investments | 58.42M | 55.89M | 9.2M | 16.29M | 43.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100.31K |
| Accounts Receivable | 10.65M | 7.95M | 9.17M | 18.66M | 33.94M | 23.22M | 8.01M | 5.34M | 3.04M | 1.02M | 1.19M | 929.29K | 901.62K | 1.01M | 600.15K | 547.14K | 338.9K | 315.37K | 279.19K | 300.5K | 98.98K | 76.34K | 75.34K | 1.91M | 44.67K | 54.04K | 86.96K | 246.44K | 486.77K | 989.91K | 1.57M |
| Days Sales Outstanding | 37.72 | 30.17 | 40.68 | 89.77 | 162.47 | 71.12 | 60.77 | 71.28 | 56.3 | 33.81 | 52.96 | 52.6 | 53.16 | 41.16 | 38.68 | 72.39 | 59.43 | 72.78 | 77.06 | 112.81 | 59.89 | 45.33 | 43.88 | 1.15K | 19.21 | 14.68 | 26.68 | 50.63 | 74.98 | 101.17 | 42.05 |
| Inventory | 35.59M | 30.16M | 29.01M | 43.46M | 34.9M | 28.34M | 11.6M | 11.12M | 3.51M | 1.85M | 1.76M | 1.83M | 965.22K | 420.92K | 656.4K | 505.96K | 410.49K | 358.22K | 625.29K | 99.06K | 92.75K | 123.41K | 94.32K | 39.8K | 18.59K | 487.86K | 653.95K | 952.3K | 1.23M | 1.65M | 2.63M |
| Days Inventory Outstanding | 309.89 | 322.81 | 370.49 | 164.33 | 434.4 | 114.56 | 205.11 | 458.25 | 206.01 | 157.66 | 186.1 | 254.16 | 111.66 | 29.62 | 71.08 | 136.23 | 122.29 | 129.84 | 296.16 | 78.08 | 113.58 | 180.13 | 209.94 | - | - | 225.77 | 887.47 | 510.62 | 350.65 | 314.68 | 166.51 |
| Other Current Assets | 0 | 9.53M | 6M | 14.31M | 6.91M | -229K | 0 | -85K | 0 | 0 | 0 | 0 | 0 | 0 | 174.73K | 0 | 0 | 0 | 0 | 0 | 190.84K | 0 | 0 | 106.41K | 25.75K | 0 | 135.55K | 79.37K | 0 | 0 | 138.25K |
| Total Non-Current Assets | 312.3M | 269.32M | 250.73M | 292.11M | 311.78M | 426.75M | 120.12M | 68.83M | 7.9M | 2.21M | 3.3M | 5.4M | 3.91M | 1.48M | 1.54M | 501.61K | 494.09K | 441.59K | 130.1K | 156.44K | 44.78K | 62.25K | 129K | 123K | 157.71K | 925.39K | 962.26K | 873.06K | 799.03K | 1.01M | 1.08M |
| Property, Plant & Equipment | 23.88M | 22.18M | 16.76M | 32.62M | 39.2M | 36.8M | 19.81M | 6.61M | 1.32M | 1.11M | 1.19M | 1.45M | 1.66M | 1.32M | 1.33M | 353.4K | 360.7K | 405.42K | 130.1K | 112.69K | 44.78K | 62.25K | 129K | 123K | 157.71K | 454.29K | 433.65K | 494.45K | 780.31K | 994.3K | 1.06M |
| Fixed Asset Turnover | 4.76x | 4.34x | 4.91x | 2.33x | 1.94x | 3.24x | 2.43x | 4.14x | 14.97x | 9.97x | 6.93x | 4.46x | 3.74x | 6.76x | 4.24x | 7.81x | 5.77x | 3.90x | 10.17x | 8.63x | 13.47x | 9.87x | 4.86x | 4.92x | 5.38x | 2.96x | 2.74x | 3.59x | 3.04x | 3.59x | 12.80x |
| Goodwill | 208.59M | 208.59M | 212.3M | 224.74M | 224.74M | 224.74M | 58.45M | 33.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.65M | 4.26M | 9.56M | 21.15M | 32.09M | 152.15M | 31.05M | 21.98M | 0 | 0 | 0 | 3.91M | 2.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 471.1K | 512.32K | 370.28K | 0 | 0 | 0 |
| Long-Term Investments | 111.85M | 31.25M | 5.62M | 13.33M | 6.4M | 4.37M | 5.87M | 2.5M | 6.55M | 1.07M | 2.08M | 0 | 0 | 0 | 0 | 0 | 36.17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.29M | 3.05M | 6.48M | -20.88M | 9.35M | 9.81M | 4.71M | 3.92M | 36K | 35.84K | 36.62K | 36.17K | 36.17K | 151.04K | 207.62K | 148.21K | 97.22K | 36.17K | 0 | 43.75K | 0 | 0 | 0 | 0 | 0 | 0 | 16.28K | 8.33K | 18.73K | 18.73K | 18.73K |
| Total Assets | 447.49M | 405.88M | 399.49M | 412.71M | 450.23M | 552.6M | 234.83M | 93.01M | 45.47M | 12.14M | 7.93M | 12.37M | 16.07M | 3.35M | 3.17M | 1.66M | 1.31M | 1.33M | 1.17M | 726.02K | 560.43K | 447.11K | 833.27K | 2.96M | 313.85K | 1.78M | 3.99M | 2.16M | 2.73M | 3.88M | 8.4M |
| Asset Turnover | 0.25x | 0.24x | 0.21x | 0.18x | 0.17x | 0.22x | 0.20x | 0.29x | 0.43x | 0.91x | 1.04x | 0.52x | 0.39x | 2.67x | 1.79x | 1.66x | 1.59x | 1.19x | 1.13x | 1.34x | 1.08x | 1.37x | 0.75x | 0.20x | 2.70x | 0.76x | 0.30x | 0.82x | 0.87x | 0.92x | 1.62x |
| Asset Growth % | 21.35% | 1.6% | -3.2% | -8.33% | -18.53% | 135.32% | 152.47% | 104.57% | 274.43% | 53.19% | -35.92% | -23.04% | 379.31% | 5.79% | 90.72% | 26.96% | -1.87% | 13.95% | 61.24% | 29.55% | 25.35% | -46.34% | -71.89% | 844.38% | -82.33% | -55.46% | 84.74% | -20.84% | -29.69% | -53.84% | -7.66% |
| Total Current Liabilities | 13.95M | 22.98M | 32.73M | 42.18M | 44.58M | 42.7M | 15.57M | 7.78M | 1.94M | 1.51M | 1.13M | 1.73M | 1.26M | 1.63M | 1.37M | 579.25K | 340.7K | 356.67K | 927.15K | 445.81K | 380.34K | 211.15K | 220.31K | 1.61M | 868.1K | 1.47M | 360.26K | 1.32M | 1.21M | 1.28M | 3.55M |
| Accounts Payable | 2.48M | 1.49M | 3.57M | 6.94M | 15.37M | 14.95M | 3.67M | 3.12M | 720K | 691K | 710.72K | 1.03M | 474.66K | 867.07K | 862.49K | 403.1K | 117.07K | 192.83K | 659.13K | 97.14K | 90.3K | 65.66K | 85.04K | 563.36K | 171.67K | 1M | 120.07K | 648.58K | 593.02K | 533.67K | 0 |
| Days Payables Outstanding | 26.01 | 15.91 | 45.63 | 26.24 | 191.25 | 60.4 | 64.92 | 128.52 | 42.27 | 58.98 | 75.24 | 142.6 | 54.91 | 61.02 | 93.4 | 108.54 | 34.88 | 69.89 | 312.18 | 76.56 | 110.57 | 95.84 | 189.28 | - | - | 462.8 | 162.94 | 347.76 | 169.62 | 101.53 | - |
| Short-Term Debt | 0 | 5M | 10.94M | 6.29M | 1.81M | 862K | 614K | 13K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.48K | 28.45K | 0 | 705.52K | 345.82K | 0 | 10.86K | 166.61K | 37.28K | 0 | 18.02K |
| Deferred Revenue (Current) | 743K | 195K | 103K | 661K | 548K | 814K | 931K | 324K | 130K | 130K | 0 | 0 | 0 | 0 | 20K | 20K | 20K | 20K | 25.83K | 8.33K | 0 | 0 | 0 | 0 | 105.8K | 0 | 0 | 0 | 367.1K | 428.32K | 0 |
| Other Current Liabilities | 3.86M | 5.93M | 5.23M | 23.21M | 20.71M | 21.52M | 6.34M | 1.96M | 159K | 130K | 344.47K | 130.22K | 130.22K | 257.88K | 119.75K | 98.83K | 95.62K | 0 | 189.46K | 0 | 0 | 0 | 0 | 0 | 244.81K | 0 | 229.34K | 504.08K | 208.42K | 278.7K | 1.7M |
| Current Ratio | 9.69x | 5.94x | 4.54x | 2.86x | 3.11x | 2.95x | 7.37x | 3.11x | 19.37x | 6.56x | 4.08x | 4.04x | 9.64x | 1.15x | 1.19x | 2.00x | 2.39x | 2.50x | 1.12x | 1.28x | 1.36x | 1.82x | 3.20x | 1.77x | 0.18x | 0.58x | 8.40x | 0.97x | 1.60x | 2.24x | 2.06x |
| Quick Ratio | 7.14x | 4.63x | 3.66x | 1.83x | 2.32x | 2.28x | 6.62x | 1.68x | 17.56x | 5.34x | 2.53x | 2.98x | 8.88x | 0.90x | 0.71x | 1.13x | 1.19x | 1.50x | 0.45x | 1.06x | 1.11x | 1.24x | 2.77x | 1.74x | 0.16x | 0.25x | 6.59x | 0.25x | 0.58x | 0.95x | 1.32x |
| Cash Conversion Cycle | 321.61 | 337.07 | 365.55 | 227.86 | 405.62 | 125.28 | 200.96 | 401 | 220.04 | 132.49 | 163.82 | 164.15 | 109.91 | 9.77 | 16.36 | 100.09 | 146.84 | 132.72 | 61.03 | 114.33 | 62.9 | 129.62 | 64.54 | - | - | -222.35 | 751.21 | 213.48 | 256.01 | 314.32 | - |
| Total Non-Current Liabilities | 13.54M | 11.02M | 17.84M | 32.87M | 41.46M | 33.54M | 14.01M | 2.21M | 380K | 538K | 3.63M | 784.46K | 874.83K | 15M | 14.29M | 12.26M | 10.52M | 8.8M | 5.41M | 2.75M | 287.77K | 197.48K | 85.04K | 1.27M | 517.49K | 1M | 130.92K | 21.45K | 90.02K | 140.94K | 874.63K |
| Long-Term Debt | 0 | 0 | 5M | 17.56M | 23.79M | 6.35M | 655K | 0 | 0 | 0 | 2.84M | 0 | 0 | 10.6M | 10.6M | 10.13M | 9.03M | 7.89M | 5.06M | 2.75M | 0 | 197.48K | 0 | 0 | 0 | 0 | 0 | 14.05K | 90.02K | 140.94K | 4.63K |
| Capital Lease Obligations | 44.85M | 10.66M | 12.72M | 8.7M | 15.09M | 16.76M | 8.77M | 550K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 576K | 189K | 124K | 114K | 250K | 5.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.81M | -10.13B | -9.03M | -7.89B | -4.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 399K | 171K | 78K | 6.5M | 2.33M | 4.94M | 4.51M | 0 | 28.9M | 538K | 685.45K | 784.46K | 874.83K | 4.39M | 3.6M | 2.03M | 1.35M | 766.97K | 278.96K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.4K | 0 | 0 | 870K |
| Total Liabilities | 27.49M | 34M | 50.58M | 75.05M | 86.04M | 76.24M | 29.58M | 9.98M | 2.32M | 2.05M | 4.76M | 2.51M | 2.14M | 16.62M | 15.66M | 12.84M | 10.86M | 9.16M | 6.34M | 3.2M | 380.34K | 408.62K | 220.31K | 1.61M | 868.1K | 1.47M | 360.26K | 1.34M | 1.3M | 1.42M | 4.42M |
| Total Debt | 15.74M | 17.9M | 30.17M | 33.83M | 43.71M | 26.88M | 11.15M | 1.35M | 0 | 0 | 2.84M | 0 | 0 | 10.6M | 10.6M | 10.13M | 9.03M | 7.89M | 5.06M | 2.75M | 197.48K | 225.93K | 0 | 705.52K | 345.82K | 0 | 10.86K | 180.66K | 127.3K | 177.92K | 53.74K |
| Net Debt | -8.26M | -15.14M | -65.21M | 5.93M | 24.27M | -42.99M | -79.3M | -5.09M | -30.66M | -6.66M | 1.44M | -3.82M | -9.94M | 10.45M | 10.41M | 10.11M | 9.03M | 7.75M | 4.96M | 2.69M | 78.8K | 40.83K | -531.68K | -82.38K | 278.71K | -286.11K | -2.14M | 172.71K | -7.88K | 53.92K | -1.06M |
| Debt / Equity | 0.04x | 0.05x | 0.09x | 0.10x | 0.12x | 0.06x | 0.05x | 0.02x | - | - | 0.90x | - | - | - | - | - | - | - | - | - | 1.10x | 5.87x | - | 0.52x | - | - | 0.00x | 0.22x | 0.09x | 0.07x | 0.01x |
| Debt / EBITDA | 1.43x | 4.96x | 19.70x | - | 3.11x | - | 6.42x | 0.89x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.75x | -4.20x | -42.57x | - | 1.73x | - | -45.68x | -3.33x | -7.66x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | 9.40x | -0.40x | -9.92x | -14.15x | -15.54x | -63.19x | -199.28x | 154.00x | -5000.00x | -4.68x | -24.26x | - | -16.41x | -0.46x | -1.26x | -1.92x | -2.37x | -4.69x | -8.75x | -19.62x | -26.43x | -322.97x | -7.77x | -26.60x | - | - | - | -37.15x | - | - | - |
| Total Equity | 420M | 371.89M | 348.91M | 337.66M | 364.19M | 480.75M | 205.25M | 83.03M | 43.15M | 10.09M | 3.17M | 9.86M | 16.07M | -13.27M | -12.49M | -11.18M | -9.55M | -7.83M | -5.17M | -2.47M | 180.09K | 38.48K | 612.96K | 1.36M | -554.25K | 310.77K | 3.63M | 818.4K | 1.43M | 2.46M | 3.98M |
| Equity Growth % | 41.82% | 6.59% | 3.33% | -7.28% | -24.25% | 134.23% | 147.21% | 92.42% | 327.55% | 218.76% | -67.89% | -38.64% | 221.08% | -6.29% | -11.68% | -17.09% | -22% | -51.36% | -109.37% | -1471.42% | 368% | -93.72% | -54.8% | 344.68% | -278.35% | -91.44% | 343.37% | -42.84% | -41.81% | -38.21% | -24.87% |
| Book Value per Share | 8.52 | 7.64 | 7.57 | 7.72 | 8.57 | 12.49 | 7.52 | 4.27 | 2.65 | 0.76 | 0.25 | 0.81 | 1.54 | -2.65 | -2.51 | -2.25 | -1.92 | -1.57 | -1.04 | -0.50 | 0.05 | 0.04 | 0.69 | 1.53 | -0.63 | 0.35 | 5.12 | 0.34 | 0.60 | 1.04 | 2.26 |
| Total Shareholders' Equity | 420M | 371.89M | 348.91M | 337.66M | 364.19M | 480.75M | 205.25M | 83.03M | 43.15M | 10.09M | 3.17M | 8.51M | 13.94M | -13.27M | -12.49M | -11.18M | -9.55M | -7.83M | -5.17M | -2.47M | 180.09K | 38.48K | 612.96K | 1.36M | -554.25K | 310.77K | 3.63M | 818.4K | 1.43M | 2.46M | 3.98M |
| Common Stock | 49K | 48K | 47K | 45K | 43K | 42K | 33K | 21K | 19K | 14.02K | 12.86K | 12.45K | 12.08K | 5.03K | 69.68K | 69.68K | 69.68K | 69.68K | 69.64K | 69.61K | 68.77K | 12.41K | 12.41K | 12.41K | 12.41K | 12.41K | 12.41K | 33.85K | 33.45K | 33.45K | 24.85K |
| Retained Earnings | -293.41M | -339.7M | -335.1M | -313.34M | -246.91M | -105.02M | -97.39M | -100.05M | -71.03M | -73.96M | -71.2M | -64.33M | -60.11M | -56.9M | -55.81M | -54.15M | -52.19M | -50.21M | -47.44M | -44.67M | -41.82M | -40.68M | -40.06M | -39.32M | -37.5M | -37.71M | -33.3M | -30.53M | -29.35M | -28.08M | -22.25M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -211K | 132K | 24K | -345K | -679K | -282K | 0 | 0 | -2.33M | -2.01M | -1.67M | -451 | -6.45K | -862.16K | -615.09K | -447.39K | -352.33K | -281.04K | -190.21K | -203.38K | -8.99K | -31.02K | -157.11K | -97.32K | -1.43M | -2.14M | -1.88M | -2.59M | -2.33M | -80K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.35M | 2.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying BLFS stock.
As of 2025, BioLife Solutions, Inc. (BLFS) had total assets of $405.9M including $136.6M in current assets.
BioLife Solutions, Inc. (BLFS) carries total debt of $17.9M, offset by $88.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
BioLife Solutions, Inc. (BLFS) has total shareholders' equity (book value) of $371.9M ($7.64 book value per share). Book value represents the net worth of the company belonging to common stock holders.
BioLife Solutions, Inc. (BLFS) reported a current ratio of 5.94x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill impairment and earnings quality
Metrics are mathematically derived from official filings.
Balance Sheet Strengthens Post-Divestiture
Total assets rose to $447.5M in 2026Q2 from $401.6M a year earlier, while liabilities fell to $27.5M, lifting equity to $420M. According to the latest balance sheet, the divestiture of freezer businesses appears to have streamlined the capital structure.
The sequential increase in equity from $372.2M in 2026Q1 to $420.0M in 2026Q2 is largely attributable to a non-operating gain, as suggested by the prior income statement analysis. This balance sheet strengthening appears more reflective of one-time items than sustainable operational improvements, given the persistent negative retained earnings. Investors should monitor whether the equity build can be sustained through core operations.
Minimal Leverage Masks Strategic Shift
Total debt declined to $15.7M in 2026Q2 from $41.0M in 2024Q1, with D/E falling to 0.04. As reported in the balance sheet data, the company appears to have used divestiture proceeds to pay down obligations, reducing refinancing risk.
The debt reduction aligns with the strategic pivot away from capital-intensive freezer manufacturing, as the company sheds lower-margin assets. With debt representing only 3.5% of total assets, leverage is not a concern, but the low debt levels also suggest limited financial flexibility for future acquisitions. The absence of significant debt implies that cash flow durability is not currently threatened by interest obligations.
Asset Mix Shifts Toward Intangibles
Goodwill remains elevated at $208.6M, representing 46.6% of total assets in 2026Q2, while PPE net is only $23.9M. Based on the balance sheet data, the company's asset base is increasingly intangible-heavy, reflecting its consumables-focused strategy.
The reduction in PPE from $32.1M in 2024Q3 to $23.9M in 2026Q2 is consistent with the divestiture of freezer operations, reinforcing the shift to an asset-light model. However, the large goodwill balance, which has remained stable despite the divestiture, raises impairment risk if the CGT market underperforms. The asset mix suggests that the company's value is tied to regulatory moats and customer relationships rather than physical assets.
Retained Deficit Persists Despite Equity Rise
Retained earnings improved to -$293.4M in 2026Q2 from -$325.1M in 2024Q1, but the deficit remains substantial. According to the balance sheet data, the equity increase is driven by a one-time gain, not cumulative profitability.
The improvement in retained earnings is largely due to the $45.1M net income in 2026Q2, which prior analysis suggests includes non-operating gains. Excluding such items, the underlying business continues to generate losses, as evidenced by the negative operating margin. The equity quality is therefore questionable, with a significant portion of the book value stemming from intangible assets and one-time events rather than retained operational profits.
Liquidity Buffer Thins as Cash Declines
Cash dropped to $24.0M in 2026Q2 from $95.4M in 2024Q4, while the current ratio improved to 9.69. As reported in the balance sheet data, the company's liquidity position appears adequate but has weakened significantly over the past year.
The sharp decline in cash is likely due to debt repayment and working capital swings, as noted in the cash flow analysis. Despite the lower cash balance, the current ratio of 9.69 indicates a strong ability to cover short-term obligations, partly because current liabilities have been reduced. However, the cash runway may be limited if operating losses persist, and the company may need to rely on its equity base or external financing to fund future growth.
Goodwill and One-Time Gains Distort Strength
Goodwill of $208.6M and a $45.1M non-operating gain in 2026Q2 inflate the balance sheet's apparent health. According to the financial statements, the underlying operating performance remains strained, suggesting the balance sheet strength may be overstated.
The balance sheet's improving metrics are heavily influenced by the divestiture and a one-time gain, which may not be repeatable. The persistent negative retained earnings and thin operating margins indicate that the core business has not yet achieved sustainable profitability. Investors should be cautious about interpreting the strong equity position as a sign of operational health, as goodwill impairment risk and earnings quality remain key concerns.